Mumbai, Feb. 13 -- Total revenue from operations jumped 24.26% year-on-year to Rs 7,167.52 crore in the quarter ended 31 December 2025.

Profit before tax stood at Rs 1,522.04 crore during the quarter, up 4207% from Rs 1,071.27 crore recorded in Q3 FY25.

EBITDA stood at Rs 2,376.6 crore in Q3 FY26, registering a 68.6% growth compared with Rs 1,409.80 crore in Q3 FY25. The EBITDA margin improved 840 basis points to 33.5% in Q3 FY26 from 25.1% in Q3 FY25.

U.S. sales for Q3 FY26 rose 54% to Rs 3,113.2 crore ($350 million) from Rs 2,022.1 crore ($240 million) in Q3 FY25, accounting for 44% of the company's global sales. During the quarter, the company received 1 ANDA approval from the U.S. FDA and launched 3 products in the U.S., taking its...